Clinical trial
Comparison of Three Methods to Evaluate Residual Disease in Multiple Myeloma
NCT02627261 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Three Methods to Evaluate Residual Disease in Multiple Myeloma
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 23, 2015
- Completion date
- September 2, 2018
- Enrollment
- 48 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.